Expansion potential Opportunity to leverage CV Sciences’ recent acquisitions and product launches to upsell distribution partnerships with retailers, supplement brands, and health-focused e-commerce platforms seeking a broader cannabinoid and wellness portfolio.

Product diversification CV Sciences has launched multiple new lines including EMPOWR plant-based protein+creatine, Aura Collection THC Fizz Tablets, and non-cannabinoid +PlusHLTH line, presenting cross-sell opportunities to co-brand with sports nutrition, functional wellness, and lifestyle brands.

Strategic acquisitions Recent acquisition of Extract Labs and Elevated Softgels indicates a growth trajectory and capability to integrate manufacturing, formulation, and distribution, offering prospects for white-labeling, contract manufacturing, or regional expansion partnerships.

Brand trust Established CBD brand PlusCBD with a broader wellness positioning creates a compelling case for retail collaborations, influencer programs, and controlled distribution to maintain product integrity while expanding shelf presence.

Data and tech readiness Utilization of analytics and performance tools (Google Analytics, Visual Website Optimizer) signals data-driven marketing potential; approach aligns with offering targeted digital campaigns, CRO services, and precision shopper marketing for retailer partners.